Assays to measure estrogen and androgen agonists and antagonists.

Substantial evidence has surfaced on the hormone-like effects of many xenobiotics in fish, wildlife and humans (Colborn et al., 1993). The endocrine and reproductive effects of xenobiotics are believed to be due to their 1) mimicking the effects of endogenous hormones such as estrogens and androgens, 2) antagonizing the effects of normal, endogenous hormones, 3) altering the pattern of synthesis and metabolism of natural hormones, and 4) modifying the hormone receptor levels. Estrogen mimics (xenoestrogens) are among the environmental chemicals found to cause reproductive impairment in wildlife and humans. All of these compounds were found to be estrogenic long after they had been released into the environment. A single causal agent can be identified in cases in which humans have had occupational exposures, whereas in cases where wildlife have shown signs of reproductive damage the exposure is usually a combination of endocrine disruptors that may have acted cumulatively. It has been hypothesized that environmental estrogens may play a role in the decrease of human semen quantity and quality of human semen during the last 50 years. They may also be partly responsible for the increased incidence of testicular cancer and cryptorchidism in males and breast cancer incidence in both females and males in the industrialized word. Testing this hypothesis will require: 1) the identification of xenoestrogens among the chemicals present in the environment, 2) the development of a methodology to assess the interactions among mixtures of xenoestrogens to which humans are exposed, and 3) the discovery of markers of estrogen exposure. The development of fast and sensitive bioassays is central to the achievement of these three goals.

[1]  B. Katzenellenbogen,et al.  Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptors. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[2]  N. Olea,et al.  Development of a marker of estrogenic exposure in human serum. , 1995, Clinical chemistry.

[3]  Roger Perkins,et al.  QSAR Models for Binding of Estrogenic Compounds to Estrogen Receptor α and β Subtypes. , 1997, Endocrinology.

[4]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. A. Doisy,et al.  An Ovarian Hormone: Preliminary Report on Its Localization, Extraction and Partial Purification, and Action in Test Animals , 1923 .

[6]  J. Nicolas,et al.  Stable luciferase transfected cells for studying steroid receptor biological activity. , 1994, Journal of bioluminescence and chemiluminescence.

[7]  L. Gray,et al.  Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. , 1994, Toxicology and applied pharmacology.

[8]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[9]  G. Jenster,et al.  A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.

[10]  D. Tindall,et al.  Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP , 1992, The Prostate.

[11]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[12]  C. Sonnenschein,et al.  Developing a marker of exposure to xenoestrogen mixtures in human serum. , 1997, Environmental health perspectives.

[13]  B. Ozenberger,et al.  Selective uptake of estrogenic compounds by Saccharomyces cerevisiae: a mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. , 1995, Endocrinology.

[14]  L. Gray,et al.  Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonist , 1995, Nature.

[15]  C. Sonnenschein,et al.  p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. , 1991, Environmental health perspectives.

[16]  D. Tindall,et al.  Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. , 1991, Cancer research.

[17]  C. Sonnenschein,et al.  Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. , 1997, Endocrinology.

[18]  C. Sonnenschein,et al.  Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. , 1984, Biochemical and biophysical research communications.

[19]  P. Chambon,et al.  Structure of the human oestrogen-responsive gene pS2. , 1987, Nucleic acids research.

[20]  C. Portier,et al.  Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. , 1997, Toxicology and applied pharmacology.

[21]  H. A. Padykula,et al.  Estrogen action in normal and abnormal cell growth , 1980 .

[22]  C Sonnenschein,et al.  The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. , 1994, Environmental health perspectives.

[23]  P. Čepický,et al.  [Estrogens in the environment]. , 1986, Ceskoslovenska gynekologie.

[24]  I. Schiff,et al.  Estrogens in the Environment II: Influences on Development , 1987 .

[25]  J. Veldscholte,et al.  Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids. , 1990, Biochimica et biophysica acta.

[26]  N. Olea,et al.  The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP. , 1990, Endocrinology.

[27]  C. Sonnenschein,et al.  Cell proliferation of estrogen-sensitive cells: the case for negative control. , 1987, Endocrine reviews.

[28]  W S Branham,et al.  Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species. , 1997, Environmental health perspectives.

[29]  J. Nicolas,et al.  Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line. , 1994, Cancer research.

[30]  D Gagne,et al.  A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. , 1990, BioTechniques.

[31]  N. Olea,et al.  Negative controls of cell proliferation: human prostate cancer cells and androgens. , 1989, Cancer research.

[32]  K. Korach,et al.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Soto,et al.  Developmental effects of endocrine-disrupting chemicals in wildlife and humans. , 1993, Environmental health perspectives.

[34]  C Sonnenschein,et al.  The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. , 1995, Environmental health perspectives.

[35]  B. Katzenellenbogen,et al.  Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells. , 1984, Cancer research.

[36]  S. Shiau,et al.  Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: a positive selection system. , 1995, Gene.